In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.
In this episode, Megan Thomas is in conversation with Dr Lynn Kirkpatrick, CEO of Ensysce Biosciences. As we all know, the opioid epidemic is one of the biggest issues in the United States today. As of late, it has been cracked down on to prevent overdosing and abuse of opioids, but it still leaves patients with a need for pain medication. Currently, Ensynsce Biosciences is headed into Phase III clinical trials with a drug that improves the care and safety of patients by preventing the possibility of both abuse and overdose of prescription drugs. Today, CEO Dr Kirkpatrick talks about how they are developing this safer option to opioid pain killers, and how it prevents abuse and overdose.